Pharmacokinetic-pharmacodynamic Assessment of Seresis® in Healthy Volunteers

NCT02191787 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Seresis®
DRUG: Placebo

Sponsor

Boehringer Ingelheim